Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.
Category: Cancer
-
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
The New York Times – Business: -
New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many
The New York Times – Business:Companies are testing dozens of similar drugs in cancers of the pancreas, lung, colon and more.
-
Dolly Parton Died After Brief Battle With Cancer
The New York Times – Music:Parton had recently canceled a Las Vegas residency because of health issues. A spokesman said she was admitted to a cancer center in Nashville on Friday.
-
Medical Journal Retracts Study Claiming Cancer Therapy Is More Effective When Given in the Morning
The New York Times – Business:In a notice flagging a series of problems with a clinical trial, the journal Nature Medicine said its editors “no longer have confidence in the integrity of the results.”
-
Supreme Court Rejects Lawsuit Against Bayer Alleging Roundup Weedkiller Caused Cancer
The New York Times – Business:The court’s decision is likely to determine the future of thousands of lawsuits against Bayer, which manufactures the weedkiller, over similar claims.
-
How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough
The New York Times – Business:The new strategy also holds promise for lung and colon tumors. Here’s how scientists discovered it.
-
American Factories Lag in Adopting A.I. This Drugmaker Is an Exception.
The New York Times – Business:A Bristol Myers Squibb plant that makes cancer drugs was the only manufacturer in the U.S. recognized for innovation by the World Economic Forum this year.
-
Supreme Court Appears Divided Over Roundup Weedkiller Case
The New York Times – Business:The case could help determine the future of thousands of lawsuits against the maker of a popular herbicide over claims that it causes cancer.
-
Two Drugs Stir Hope for Treatment of Deadly Pancreatic Cancer
The New York Times – Business:In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses in oncology.
-
A Cancer Detection Test Fails in Major Study
The New York Times – Business:A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in later stages of the disease.
-
A Study Is Retracted, Renewing Concerns About the Weedkiller Roundup
Problems with a 25-year-old landmark paper on the safety of Roundup’s active ingredient, glyphosate, have led to calls for the E.P.A. to reassess the widely used chemical.